Large Cap Archives - Page 321 of 437

1 minute read

Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine

By Vandana Singh

May 2, 12:14 PM

Johnson & Johnson's (NYSE: JNJ) pharma unit Janssen

GILD

1 minute read

Gilead vs. CDC: The $1B Showdown Over HIV Drug Profits

By Vandana Singh

May 2, 12:08 PM

Gilead Sciences Inc (NASDAQ: GILD) is reportedly looking to fight claims that it owes the U.S. government a share of over $1 billion in profits from its HIV-treatment drug Truvada that could help prevent the disease.

GILD

1 minute read

Why InMode Stock Is Plunging Today

By Vandana Singh

May 2, 10:42 AM

InMode Ltd (NASDAQ: INMD) sock is plunging today after the company reported a Q1 earnings beat, but the annual outlook lagged expectations.

INMD

2 minute read

HSBC Q1 Profit Triples On Strong NII, Declares First Quarterly Dividend Since 2019

By Lekha Gupta

May 2, 10:13 AM

HSBC Holdings PLC (NYSE:HSBC) reported a Q1 2023 revenues increase of 64% Y/Y to $20.2 billion (+74% Y/Y in constant currencies).…

HSBC

1 minute read

AmerisourceBergen Boosts 2023 Earnings Outlook, As Q2 Profits, Sales Beat Estimates

By Vandana Singh

May 2, 9:57 AM

AmerisourceBergen Corp's (NYSE: ABC) Q2 FY23 adjusted EPS reached $3.50, up 8.7% Y/Y,

ABC

1 minute read

What’s Going On With Stryker Stock Today

By Vandana Singh

May 2, 9:49 AM

The orthopedic and surgical device giant Stryker Corporation (NYSE: SYK) stock is trading lower despite reporting Q1 earnings beat and an upbeat outlook.

SYK

1 minute read

Hush-Hush Healthcare Feud: UnitedHealthcare to Cough Up $91 Million in Arbitration Over Billing Practices

By Vandana Singh

May 2, 9:39 AM

Three arbitrators ruled that UnitedHealthcare Group Inc (NYSE: UNH) must pay damages of $91 million in a 2018 dispute over billing practices that disappeared from public view after the proceedings moved from federal court to a secretive arbitration panel.

KKR